2022-02-162022-02-162012-09Avcı, N. vd. (2012). "Activity and safety of a combination of Epirubicin, Docetaxel and Cisplatin as neoadjuvant treatment for locally advanced breast cancer (LABC): A preliminary report". Annals of Oncology, 23, Supplement 9, 129-129.0923-7534https://www.sciencedirect.com/journal/annals-of-oncology/vol/23/suppl/S9http://hdl.handle.net/11452/24493Bu çalışma, 28 Eylül-02 Ekim 2012 tarihleri arasında Vienna[Austria]’da düzenlenen 37. Congress of the European-Society-for-Medical-Oncology (ESMO)’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessOncologyMeeting Abstract00030940900035312912923Supplement 9Oncology